Cross-Sector entity
Weiss Ratings is the most frequent co-covered peer, appearing in 9 of the 20 tracked stories. Across a 37-day span, the pace is roughly 3.8 stories per week. The busiest single day carried 5. The clearest coverage concentration is earnings: 3 of 20 stories, with the rest divided among 15 other categories.
118 verified stories tracked
Last mentioned: 3d ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 30 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Weiss Ratings is the most frequent co-covered peer, appearing in 9 of the 20 tracked stories. Across a 37-day span, the pace is roughly 3.8 stories per week. The busiest single day carried 5. The clearest coverage concentration is earnings: 3 of 20 stories, with the rest divided among 15 other categories. Each carries 2 original sources on average. Bank of America appears in 20 tracked Cross-Sector stories published from August 4, 2026 through September 9, 2026. Negative sentiment appears in 30% of the tracked stories.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bank of America. Shared-story counts are live from our verified record — not editorial picks.
CP2 Final Investment Decision
Anticipated milestone for the next-generation CP2 project expansion.
Wall Street Zen rating actions
Wall Street Zen upgraded Tenaya from strong sell to sell and argenx from hold to buy.
FGV Capital launch and Fund II close
Fiat Ventures announces the combination of its venture and advisory divisions under FGV Capital and the $35 million close of Fund II.
Deutsche Bank downgrades argenx
Deutsche Bank cut argenx from buy to hold.
Truist raises argenx target
Truist Financial lifted its argenx target from $1,030.00 to $1,095.00 with a buy rating.
AECOM Reports Q2 Loss and Issues FY2026 Guidance
AECOM posted a Q2 loss of $0.50 per share on $3.59B revenue and guided FY2026 EPS to $3.95-$4.15, far below consensus.
Amentum Updates FY2026 Guidance
Amentum guided FY2026 EPS to $2.40-$2.50 and revenue to $13.8B-$14.0B, missing revenue consensus.
Senate report released
Democrats on the Senate Finance Committee publish a report detailing the banks’ roles in facilitating Epstein’s financial activities.
Tenaya Q2 miss
Tenaya reported EPS of -$0.20 versus -$0.07 expected and revenue of $1.11 million versus $10 million consensus.
Weiss Ratings upgrades Tenaya
Weiss Ratings moved Tenaya from sell (e+) to sell (d-), still within sell territory.
Baird raises argenx target
Robert W. Baird raised argenx target from $867.00 to $932.00 with a neutral rating.
Zacks Upgrades Amentum
Zacks Research upgraded Amentum from 'hold' to 'strong-buy'.
argenx Q2 beat
argenx reported EPS of $7.32 versus $5.86 expected and revenue of $1.54 billion.
Bank of America Cuts Amentum Target
Bank of America lowered its price target on Amentum to $30 from $35, keeping a neutral rating.
JPMorgan Cuts Target; Stock Jumps
JPMorgan reduced its PG price target from $164 to $162 with an Overweight rating; P&G declared a $1.0885 dividend and the stock rose 2.3% on cost‑cut news.
Bank of America Revises Down
Bank of America lowered its PG price objective from $170 to $166, keeping a Buy rating.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
BofA extends $520M loan to OpenAI
Bank of America provides its first $520 million credit line to OpenAI ahead of the company's planned IPO.
BofA lifts argenx target
Bank of America raised its price objective on argenx from $1,016.00 to $1,088.00 with a buy rating.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
Oil above $100 and record diesel at $5.94 are driving freight, fuel, and logistics costs higher just as the Strait of Hormuz disruption removes about one-fifth of global oil supply. Supply chain and procurement teams face renewed cost pressure and route risk.
Brent crude's move above $100.72 and Bank of America's warning that a durable Iran deal is unlikely before U.S. midterms represent a geopolitical and inflation risk event. Commodity traders and equity investors must reprice energy-linked exposure.
Brent above $100 and the shutdown of the Strait of Hormuz reinforce the volatility and security risks of fossil fuel dependence. For climate and energy professionals, the shock strengthens the economic case for renewables, storage, and electrification.
Source: wokv.com · dailycamera.com
A Sunday morning research note lifted Wall Street Zen's view on two biotechs—argenx to buy and Tenaya from strong sell to sell—but the market implications diverge sharply. Finance readers get a comparison of a profitable $63 billion rare-disease leader trading at a 38.67 P/E against a $148.75 million speculative gene therapy name at -1.25 P/E.
Wall Street Zen upgraded Tenaya from strong sell to sell, but the micro-cap gene therapy company still trades near a 52-week low after a sharp Q2 EPS and revenue miss. Biotech readers get a closer look at how clinical-stage execution failures are reflected in rating actions, while argenx's profitable rare disease business shows what commercial success looks like.
Source: tickerreport.com · dailypolitical.com
Lululemon's Q3 guidance implies a 62% EPS gap to consensus and an 11.5% revenue shortfall, signaling accelerating weakness in premium athleisure demand. The reset comes even as shares rose 1.4% on heavy volume, suggesting bad news was largely priced in. Retailers and DTC brands should read this as a leading indicator of softening consumer demand for discretionary premium apparel.
Source: MarketBeat · tickerreport.com
Kanzhun (BOSS Zhipin) reported Q2 revenue of $353.05 million and a 40.21% net margin, showing robust employer demand for digital recruitment in China. The slight revenue miss is offset by an EPS beat of $0.33 against $0.32, reinforcing the platform's pricing power.
Kanzhun reported Q2 EPS of $0.33, beating by $0.01, but revenue of $353.05 million missed consensus by $1.58 million. With a $6.33 billion market cap, 15.14 P/E, and beta of 0.48, analysts see Moderate Buy with an average target of $18.67.
Source: Watch List News · Ticker Report
FGV Capital launched with a $35 million Fund II and a combined venture-advisory model that lets founders tap a network of industry executives. The firm's pitch is that taking investment also unlocks go-to-market support through Fiat Growth. It marks a bid by an emerging manager to win cap-table spots in a tougher fundraising environment.
FGV Capital's $35 million Fund II closes with Bank of America, MassMutual, and Reinsurance Group of America as limited partners. The firm is folding its advisory and venture operations under one brand while keeping investment and consultancy arms separate. Institutional LP selection signals a focus on strategic partnerships beyond pure capital.
Source: TechCrunch · finance.yahoo.com
CIBC's appointment of Prasanna Gopalakrishnan signals that technology and AI governance are now board-level priorities for Canadian banks. Her background spans ADP, Sky, and Bank of America retail banking, bringing product and operational depth.
Source: Winnipeg Free Press · Squamish Chief
Mitsubishi UFJ's Q2 13F shows a 22.3% reduction in Nike and 6.4% in Zoetis, just as sell-side targets on NKE cluster at $42–$47. For finance professionals, the filings highlight institutional rebalancing, ownership concentration, and analyst caution as key sentiment signals.
Source: Ticker Report · Watch List News
Engineering services giants AECOM and Amentum both released disappointing FY2026 outlooks on August 10, 2026. AECOM's EPS guidance of $3.95–$4.15 was far below the $5.97 consensus, while Amentum's revenue guidance missed estimates by up to $400 million. The news sent both stocks lower, deepening recent slumps.
Source: dailypolitical.com · themarketsdaily.com
Jim Cramer attributes Amazon’s recent stock movement to a market rotation into hyperscaler stocks, while Prime Day sell-through data signals accelerating e-commerce demand. With Bank of America and TD Cowen issuing bullish notes, the retail and cloud giant is positioned for a strong Q2, potentially hitting $200B in revenue.
Source: insidermonkey.com · finance.yahoo.com
A new Senate report exposes that JPMorgan, Deutsche Bank, and Bank of America permitted more than $1.1 billion in suspicious transfers by Jeffrey Epstein, raising the specter of massive regulatory fines, litigation, and stricter AML rules for the financial industry.
A Senate Finance Committee report reveals that JPMorgan, Deutsche Bank, and Bank of America ignored blatant AML red flags over two decades, processing over $1.1 billion in suspicious Epstein transactions. The findings expose the banks to substantial civil and criminal liability under the Bank Secrecy Act.
Source: chinanationalnews.com · coloradostar.com
CBRE Group's above-consensus EPS guidance underscores the commercial real estate sector's momentum, driven by technology-driven services. For PropTech startups and investors, it signals growing client spending on smart buildings, data analytics, and digital brokerage platforms.
Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline.
Teva's fiscal 2026 EPS guidance, well below the Street's $2.17, raises red flags for biotech and pharma investors. However, a $42 average price target and stable revenue suggest a value play if the biosimilar pipeline delivers.
Source: tickerreport.com · themarketsdaily.com
Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78.
